The T-box factor TBX-2 and the SUMO conjugating enzyme UBC-9 are required for ABa-derived pharyngeal muscle in C. elegans  by Roy Chowdhuri, Sinchita et al.
95 (2006) 664–677
www.elsevier.com/locate/ydbioDevelopmental Biology 2The T-box factor TBX-2 and the SUMO conjugating enzyme UBC-9
are required for ABa-derived pharyngeal muscle in C. elegans
Sinchita Roy Chowdhuri a, Tanya Crum a, Alison Woollard b, Sobia Aslam b, Peter G. Okkema a,⁎
a Department of Biological Sciences (MC567), University of Illinois at Chicago, 900 S. Ashland Avenue, Chicago, IL 60607, USA
b Department of Biochemistry, University of Oxford, UK
Received for publication 29 September 2005; revised 29 March 2006; accepted 3 April 2006
Available online 7 April 2006Abstract
The C. elegans pharynx is produced from the embryonic blastomeres ABa and MS. Pharyngeal fate in the ABa lineage is specified by the
combined activities of GLP-1/Notch-mediated signals and the TBX-37 and TBX-38 T-box transcription factors. Here, we show another T-box
factor TBX-2 also functions in ABa-derived pharyngeal development. tbx-2 mutants arrest as L1 larvae lacking most or all ABa-derived
pharyngeal muscles. In comparison, tbx-2 mutants retain ABa-derived marginal cells and pharyngeal muscles derived from MS. A tbx-2∷gfp
translational fusion is expressed in a dynamic pattern in C. elegans embryos beginning near the 100-cell stage. Early expression is limited to a
small number of cells, which likely include the ABa-derived pharyngeal precursors, while later expression is observed in body wall muscles and a
subset of pharyngeal neurons. TBX-2 contains 2 consensus sumoylation sites, and it interacts in a yeast two-hybrid assay with the UBC-9 and
GEI-17 components of the C. elegans SUMO-conjugating pathway. ubc-9(RNAi) has been previously shown to cause variable embryonic and
larval arrest, and we find that, like tbx-2 mutants, ubc-9(RNAi) animals lack ABa-derived pharyngeal muscles. ubc-9(RNAi) also alters the
subnuclear distribution of TBX-2∷GFP fusion protein, suggesting that UBC-9 and TBX-2 interact in C. elegans. Together, these results indicate
that TBX-2 and SUMO-conjugating enzymes are necessary for ABa-derived pharyngeal muscle, and we hypothesize that TBX-2 function requires
sumoylation. Sumoylation is increasingly recognized as an important mechanism controlling activity of many nuclear factors, and these results
provide the first evidence that T-box factor activity may require sumoylation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Pharyngeal muscle; T-box; C. elegans; Tbx2 subfamilyIntroduction
T-box transcription factors play important roles in the
development of multicellular organisms, where their functions
include the specification of primary germ layers and specifi-
cation of cell fates during organogenesis (reviewed in Showell
et al., 2004). The importance of this gene family is emphasized
by recent observations that T-box gene mutations underlie a
number of human congenital diseases (reviewed in Packham
and Brook, 2003), and that altered T-box gene expression is
associated with human cancers (Dorfman et al., 2004, 2005; Ito
et al., 2005; Rowley et al., 2004).⁎ Corresponding author. Fax: +1 312 413 2691.
E-mail address: okkema@uic.edu (P.G. Okkema).
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doi:10.1016/j.ydbio.2006.04.001The defining feature of T-box genes is the T-box itself, which
encodes an evolutionarily conserved 180- to 200-residue DNA
binding domain. Multiple T-box genes are present in the
genome of all metazoans, and many of these genes can be
grouped into distinct subfamilies based on the T-box protein
sequence (Papaioannou, 2001). Among these subfamilies, the
vertebrate Tbx2 subfamily has recently received attention
because of its role in heart development (reviewed in Plageman
and Yutzey, 2005). The Tbx2, Tbx3, and Tbx5 members of this
subfamily are expressed in the developing heart of vertebrate
embryos, and Tbx2 and Tbx5 mouse mutants exhibit heart
defects (Bruneau et al., 2001; Christoffels et al., 2004;
Harrelson et al., 2004; Horb and Thomsen, 1999). Likewise,
mutations in human TBX5 underlie Holt-Oram syndrome,
which includes heart and limb defects (Basson et al., 1997; Li
et al., 1997). In the heart, Tbx5 protein interacts directly with
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2.5, and together, they synergistically activate target genes
(Bruneau et al., 2001; Hiroi et al., 2001).
The C. elegans T-box gene family consists of 20 members
(Pocock et al., 2004). Most of these are significantly diverged
from T-box genes in other organisms, suggesting that they have
evolved specific functions in nematodes. However, 4 of the C.
elegans T-box genes are highly related to those in other species.
These include the Tbx20 subfamily member mab-9 functioning
in hindgut development (Woollard and Hodgkin, 2000), the
Tbx1 subfamily member mls-1 specifying post-embryonic
muscles (Kostas and Fire, 2002), the ascidian T2-related gene
tbx-7 (Agulnik et al., 1997; Papaioannou, 2001), and the Tbx2
subfamily member tbx-2 (Agulnik et al., 1997; Miyahara et al.,
2004).
tbx-2 is the sole Tbx2 subfamily member in the C. elegans
genome. Its T-box is closely related to all members of this
subfamily, but it shares highest amino acid identity with the
Tbx2/Tbx3 proteins (e.g., the C. elegans TBX-2 T-box is 73%
identical to those of human TBX2 and TBX3, compared to
61% and 60% identical to human TBX4 and TBX5,
respectively). tbx-2 has previously been shown to be
expressed in a subset of pharyngeal and non-pharyngeal
neurons in larvae, and weak tbx-2 mutants exhibit defective
olfactory adaptation (Miyahara et al., 2004). However, large-
scale RNAi analyses suggest that tbx-2 is required for viability
(Simmer et al., 2003), and genome wide in situ hybridization
and microarray screens suggest that tbx-2 is expressed in the
embryonic pharynx (Gaudet and Mango, 2002; Kohara,
2001).
The C. elegans pharynx is a rhythmically contracting
neuromuscular organ that pumps bacteria through its central
lumen during feeding. It consists of 80 cells of five different
types, including muscles, neurons, epithelial cells, gland cells,
and marginal cells (Albertson and Thomson, 1976). While
nematodes do not have hearts, the pharyngeal muscles share
functional and molecular similarities with cardiac muscle in
other species. Pharyngeal muscle function, like that of
vertebrate cardiac muscle, does not require nervous system
input (Avery and Horvitz, 1989). Likewise pharyngeal muscle
development does not involve the MyoD family of myogenic
regulatory factors (Chen et al., 1994; Krause et al., 1990).
Instead pharyngeal muscle development involves the NK-2
family homeobox gene ceh-22 (Okkema and Fire, 1994;
Okkema et al., 1997), which is similar to Drosophila tinman
and the vertebrate nkx2.5-related genes that play critical roles in
heart development (for review, see Harvey et al., 2002; Prall
et al., 2002).
The pharynx is produced during embryogenesis from the
ABa and MS blastomeres, which give rise to the anterior and
posterior pharynx, respectively, as well as a variety of non-
pharyngeal tissues (Sulston et al., 1983). The fates of these
blastomeres are specified by different mechanisms (reviewed in
Bowerman, 1998; Maduro and Rothman, 2002). MS fate is
autonomously specified by maternally provided SKN-1 tran-
scription factor (Bowerman et al., 1992, 1993). SKN-1 is
believed to activate zygotic expression of a pair of nearlyidentical and genetically redundant GATA family transcription
factors, MED-1 and MED-2 (Maduro et al., 2001). Inactivation
of med-1/2 by RNAi results in animals lacking posterior
pharynx and exhibiting other patterning defects. In contrast,
ABa fate is conditionally specified by activation of maternally
supplied GLP-1/Notch receptor at the 12-cell stage (Hutter and
Schnabel, 1994; Mango et al., 1994; Priess et al., 1987; Priess
and Thomson, 1987; Yochem and Greenwald, 1989). Loss of
glp-1 results in animals lacking anterior pharynx and exhibiting
patterning defects (Priess et al., 1987). Zygotic function of 2
related and genetically redundant T-box transcription factors
TBX-37 and TBX-38 is necessary for ABa-derived pharynx
(Good et al., 2004). tbx-37/38 are transiently expressed in all
ABa descendants at the 24-cell stage of embryogenesis, and tbx-
37/38 loss results in animals lacking anterior pharynx and
exhibiting defects in body elongation. Elegant genetic analyses
revealed that tbx-37/38 function in parallel to GLP-1/Notch
signals to promote ABa pharyngeal development (Good et al.,
2004).
Here, we examine the role of C. elegans tbx-2 in pharyngeal
development by characterizing the loss-of-function phenotype.
We find that tbx-2 is specifically required for development of
ABa-derived pharyngeal muscles. A tbx-2∷gfp reporter is
expressed in a dynamic pattern during embryogenesis, includ-
ing in likely precursors of ABa-derived pharynx. In addition, we
have found that TBX-2 interacts with the UBC-9 and GEI-17
components of the protein sumoylation pathway. Like tbx-2,
ubc-9 is also required for the development of ABa-derived
pharyngeal muscles, and ubc-9 loss alters the subnuclear
distribution of TBX-2∷GFP protein. We hypothesize that tbx-
2 functions to specify the identity of ABa-derived pharyngeal
muscles, and this function requires sumoylation of TBX-2
protein.
Materials and methods
Nematode handling, transformation, and strain construction
C. elegans were grown under standard conditions (Lewis and Fleming,
1995). Germ line transformation was performed using standard techniques with
pRF4 containing rol-6(su1006) as a dominant marker for transformation (Mello
and Fire, 1995).
The chromosomally integrated ceh-22∷gfp reporter OK0507 [cuIs22 III]
bearing pOK185.01 + pRF4 was derived from OK0469 [cuEx363] following
EMS mutagenesis (Anderson, 1995) and was outcrossed twice to N2. OK0536
[rrf-3(pk1426) II; cuIs22/+ III] was constructed, but we were unable to isolate
cuIs22 homozygotes in this background. The pattern and intensity of GFP
expression are identical in OK0507 and OK0536.
tbx-2(ok529)/mT1 was obtained from the C. elegans Gene Knockout
Consortium, and tbx-2(tm282)/eT1was obtained from the National BioResource
Project. OK0460 [tbx-2(ok529)/dpy-17(e164) unc-32(e189)] was constructed to
facilitate identification of arrested tbx-2(ok529) homozygotes. tbx-2(ut180) and
tbx-2(ut192) were provided by I. Katsura, and tbx-2(gm111) was provided by G.
Garriga.
Single worm PCR genotyping for tbx-2(ok529)
Individual animals were genotyped for tbx(ok529) and tbx-2(+) by single
worm duplex PCR using primers OK604 (TTTTGTGCGAACATCGACC),
OK605 (ACACACACACCTACAGTAATGCG), and OK606 (TCAGGCGAG-
CATTGGATG) under conditions similar to those previously described (Beaster-
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zygotes were confirmed by PCR during phenotypic analyses.
General methods for nucleic acid manipulations
Standard methods were used to manipulate plasmid DNAs and oligonucleo-
tides (Ausubel, 1990), and all plasmid sequences are available from the authors.
The ceh-22∷gfp fusion pOK185.01 (kindly provided by T. Vilimas) contains an
SphI to XhoI ceh-22 promoter fragment (bp 14719 to 17467 of F29F11,
accessionZ73974) (Kuchenthal et al., 2001) fused to a gfp∷his2B orf derived
from SEM474 (Gaudet and Mango, 2002) to promote tight nuclear localization
of GFP.
For constructing a full-length tbx-2∷gfp translational fusion, a tbx-2 genomic
DNA fragment was PCR amplified in 2 halves using F21GENF1 (CCGCCAC-
GAAGATATATGATCTCC) and F21GENR2 (CTACACGAGTTATGGCGGT-
TTGAGC), and F21GENF2 (5′CCTTGTTCTCCGTTCGATTCTGCATAGAC3′)
and F21GENR1 (5′CATGGGCTTTGGTTGGTGCATCATC3′). Both halves
were cloned into vector pCR2.1, and these fragments were fused at a unique
PacI site, and the complete tbx-2 genomic fragment was subcloned into
Bluscript KS+ (Stratagene) (pAW197). The tbx-2 coding sequence was
sequenced to confirm its integrity. The full-length tbx-2∷gfp translational fusion
plasmid pAW209 was constructed by inserting the gfp cassette from pPD119.45
(kindly provided by Dr. A. Fire) in frame into a unique HindIII site near the 3′
end of the tbx-2 coding sequence in exon 5 in pAW197. A tbx-2∷gfp
containing the tbx-2 promoter fused to gfp in tbx-2 exon 1 (pOK206.30) was
constructed by PCR amplifying the tbx-2 promoter region from pAW209 with
PO752 (CAGTCACGACGTTGTAAAACGACGGC, located in KS+) and
PO753 (TGTAGATCTCGTCCAAGTGCAAATGGATTG) and subcloning this
promoter using PstI and BglII into the PstI and BamHI sites of pPD95.67
(kindly provided by Dr. A. Fire).
The tbx-2 bait plasmid pOK187.01 for the yeast two-hybrid screens
contained the full-length tbx-2 orf from cDNA yk112c4 (Miyahara et al., 2004)
cloned into pLexA-NLS (Bartel and Fields, 1995). The tbx-2 orf was PCR
amplified from yk112c4/pOK165.07 using PO618 (TCCCCCCGGGAATGG-
CATTCAATCCATTTGC) and PO619 (TCCGCTCGAGCACACCGT-
TAAAAAGCTCGTTC) and cloned into pLexA-NLS using primer derived
XmaI and XhoI sites. The entire tbx-2 orf was sequenced to confirm its integrity.
RNAi analyses
RNAi analyses were performed essentially as previously described (Fire et
al., 1998). dsRNAs produced by in vitro transcription (Ambion) were injected
at approximately 200–500 ng/μl into the germline of young adult
hermaphrodites, which were allowed to recover and transferred every 8–
10 h to freshly seeded plates. Phenotypes were scored in F1 progeny.
Uninjected worms were grown in parallel as a control. RNAi experiments in
wild-type backgrounds were performed at 20°C, while those in rrf-3(pk1426)
were performed at 16°C. For all med-1(RNAi) experiments, embryos produced
8–20 h post-injection (16°C) were scored, as these exhibited the most
penetrant phenotype (>50%). Templates for RNA synthesis were amplified
from cDNA containing plasmids using primers containing a promoter for either
T3 or T7 RNA polymerase. For tbx-2(RNAi) experiments, both full-length
RNAs and RNAs lacking the T-box produced identical phenotypes. cDNAs for
tbx-2, ubc-9, and gei-17 RNAi were yk112c4/pOK165.07, yk390f7/
pOK198.01, and yk54g8/pOK186.28, respectively (kindly provided by Y.
Kohara). cDNAs for glp-1 and med-1 RNAi were pMM379 and pMM239
(kindly provided by M. Maduro).
Yeast two-hybrid screen
L40 yeast contain HIS3 and lacZ reporters regulated by LexA binding sites,
allowing two-hybrid interactions to be identified by His prototrophy and ß-gal
expression. L40 bearing the tbx-2 bait plasmid pOK187.01 were transformed
with the oligo-dT primed C. elegans pACT-RB1 cDNA library (kindly provided
by R. Barstead), and 2 screens for interactions were performed. In a high
stringency screen, these cells were plated directly on selective media (SD-Trp-
Leu-His + 2.5 mM 3AT). In a moderate stringency screen, co-transformed cellswere first isolated by plating on SD-Trp-Leu and replated on selective media
(SD-Trp-Leu-His + 2.5 mM 3AT). Yeast colonies arising in 3–7 days (30°C)
under selective conditions were streaked on SD-Trp-Leu-His + 2.5 mM 3ATand
SD-Trp-Leu + X-gal, and colonies reproducibly growing under selective
conditions and expressing lacZ were analyzed. Library plasmids containing C.
elegans cDNAs were isolated from these yeast by transformation in E. coli and
retransformed into L40 bearing pOK187.01 and L40 bearing the empty bait
plasmid pLexA-NLS. These cells were plated on SD-Trp-Leu-His + 2.5 mM
3AT and SD-Trp-Leu + X-gal to confirm reproducibility and specificity of the
interactions. The identity of the C. elegans cDNAs encoding TBX-2 interacting
proteins was found by partial sequencing using primer PO343 (TACCACTA-
CAATGGATGATG) located in the pACT plasmid followed by BLAST analysis
(http://www.wormbase.org). In the high stringency screen, 5.3 × 105 clones were
screened, and 3 plasmids specifically interacting with pOK187.01 were
identified. In the medium stringency screen, 9.9 × 105 clones were screened,
and 27 plasmids specifically interacting with pOK187.01 were identified. One
ubc-9 cDNAwas isolated in the high stringency screen, and a total of 20 gei-17
cDNAs were isolated in both screens. cDNAs for 4 additional genes were
isolated and will be discussed elsewhere.
Immunostaining and microscopy
Mixed worms segregating from the strain tbx-2(ok529)/dpy-17(e164) unc-32
(e189) were stained with antibodies 5–11, 3NB12, and MH4 (obtained from D.
Miller, B. Bowerman, and the DSHB) following freeze-crack permeabilization
under standard conditions (Miller and Shakes, 1995). tbx-2(ok529) homo-
zygotes were identified as arrested L1s with pharyngeal defects. Worms were
visualized using a Zeiss Axioskop microscope equipped for DIC and
fluorescence microscopy, and images were captured using an Axiocam camera
and AxioVision software.Results
tbx-2 is required for pharyngeal development
We first examined the tbx-2 loss-of-function phenotype by
characterizing several tbx-2 mutant strains and found loss of
tbx-2 resulted in profound pharyngeal defects. tbx-2(ok529) is
an allele obtained from the C. elegans Gene Knockout
Consortium deleting exon 4. This deletion is not predicted to
affect the tbx-2 reading frame but deletes sequences encoding
TBX-2 residues 178–226, which include the e–e′, e′–f, and g-
α3 loops of the T-box that make major contacts with the DNA
major groove (Coll et al., 2002). tbx-2(ok529) homozygotes
arrested after hatching as L1 larvae in which the anterior half of
the pharynx was particularly affected, with most worms
displaying either a long buccal cavity or an unattached pharynx
(Pun) (Figs. 1A–C). Even in cases where the pharynx was
attached to the exterior, tbx-2(ok529) animals were unable to
ingest food (data not shown), indicating that pharyngeal
function was severely compromised. Outside the pharynx,
these mutants appeared fairly normal. The L1 arrest phenotype
of tbx-2(ok529) was recessive and completely penetrant (data
not shown). Other strong tbx-2mutants characterized, including
the deletion allele tbx-2(tm282) and tbx-2(gm111) (obtained
from the National BioResource Project and Gian Garriga),
exhibited larval lethality and pharyngeal abnormalities similar
to tbx-2(ok529). In contrast, the weak alleles tbx-2(ut180) and
tbx-2(ut192) encoding missense mutations in the T-box did not
show any lethality or pharyngeal defects (Miyahara et al.,
2004).
Fig. 1. tbx-2 loss-of-function results in pharyngeal defects. (A–D) DIC
micrographs showing the pharynx of wild-type (A), tbx-2(ok529) (B and C),
and tbx-2(RNAi) (D) L1 larvae. Arrowheads indicate the extent of the pharynx.
The wild-type pharynx is a symmetric bi-lobed organ surrounded by a visible
basement membrane (bm), with a refractile lumen extending through the center.
The tbx-2mutant pharynxes exhibit defects in the anterior pharynx. The terminal
bulb (tb) exhibiting more normal morphology is indicated in panels A and B.
Note the buccal cavity (bc) is elongated in panel B and detached from the
exterior in panels C and D. (E, F) DIC micrographs showing the pharynx of a
tbx-2(RNAi) L4 (E) and wild-type (F) L4 larvae. The pharyngeal isthmus (i) is
labeled. Anterior is left; scale bar indicates 20 μm.
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geal defects similar to those observed in the strong tbx-2
mutants. In the RNAi-sensitive strain rrf-3(pk1426) (Simmer
et al., 2002), tbx-2(RNAi) resulted in nearly completely
penetrant L1 arrest with these animals exhibiting long buccal
cavities or Pun phenotypes similar to those of tbx-2(ok529)
(data not shown). In comparison, the tbx-2(RNAi) phenotypes
produced in a wild-type strain were somewhat less penetrant
and more variable. Approximately 1/3 of the treated worms
arrested as early L1 larvae, with pharyngeal defects similar to
tbx-2(ok529) (Fig. 1D). Another 1/3 of the tbx-2(RNAi)-treatedanimals grew slowly to adulthood and exhibited a thick
pharyngeal isthmus (Figs. 1E, F). This thick isthmus
phenotype was similar to a partially penetrant phenotype of
mutants defective in the pharyngeal muscle-specific NK-2
homeobox gene ceh-22 (Okkema et al., 1997), suggesting that
tbx-2 and ceh-22 have common functions in the pharyngeal
muscles. We asked if loss of both tbx-2 and ceh-22 would
result in a synthetic phenotype by examining tbx-2(RNAi);
ceh-22(cc8266) double mutants, but these animals were
indistinguishable from tbx-2(RNAi) single mutants (data not
shown).
Despite the severe defects in tbx-2 mutant pharynxes,
pharyngeal cell-type-specific differentiation occurred in these
animals. Pharyngeal muscle expression of the MYO-2 myosin
and the antigen recognized by MAb 3NB12 occurred in tbx-2
(ok529) mutants (Figs. 2A–D). Likewise, strong staining of
intermediate filaments was detected in tbx-2(ok529) marginal
cells extending the length of the pharynx, although the
organization of these filaments was disrupted (Figs. 2E, F).
Thus, pharyngeal cells can be specified and differentiated in the
absence of tbx-2.
tbx-2 is required for ABa-derived pharyngeal muscle cells
The homeobox gene ceh-22 is the earliest marker of
pharyngeal muscle differentiation, and it is specifically
expressed in 21 pharyngeal muscle cells forming the m3, m4,
m5, and m7 pharyngeal muscle types (Okkema and Fire, 1994).
To more carefully characterize the effect of tbx-2 loss, we
examined expression of a ceh-22∷gfp reporter encoding a
nuclear localized GFP protein, which allowed us to identify and
count the ceh-22 expressing pharyngeal muscle cells. In tbx-2
(+) backgrounds, ceh-22∷gfp reporter expression was detected
in all appropriate muscle types, although this expression was
somewhat mosaic and was detected in an average of
approximately 17 cells per animal (Tables 1 and 2; Figs. 3A,
B). In comparison, we found the number of ceh-22∷gfp
expressing cells was reduced in both tbx-2(ok529) and tbx-2
(RNAi) animals to approximately 12 (Tables 1 and 2; Figs. 3C,
D). Thus, tbx-2 function is essential for a subpopulation of
pharyngeal muscles.
In wild-type embryos, ceh-22 is expressed in 7 ABa-derived
pharyngeal muscles predominantly located in the anterior
pharynx and in 14 MS-derived pharyngeal muscles predomi-
nantly located in the posterior pharynx (Sulston et al., 1983).
Both the pharyngeal morphology and the number of ceh-
22∷gfp expressing cells in tbx-2 mutants are consistent with a
defect in anterior pharynx, and we hypothesized tbx-2 was
required for ABa-derived pharyngeal muscles. To test this
hypothesis, we used glp-1(RNAi) or med-1(RNAi) to genetically
ablate ABa- or MS-derived pharynx, respectively, in either tbx-
2(+) or tbx-2(RNAi) animals expressing ceh-22∷gfp. To obtain
highly penetrant phenotypes, these experiments were performed
in an RNAi hypersensitive rrf-3(pk1426) mutant background
(Simmer et al., 2002). This strain included a chromosomally
integrated ceh-22∷gfp reporter encoding a nuclear-localized
GFP (cuIs22) to facilitate counting ceh-22∷gfp expressing
Fig. 2. tbx-2 mutants produce differentiated pharyngeal muscles and marginal cells. Fluorescence micrographs of tbx-2(ok529) mutant (left column) and wild-type
(right column) L1 larvae stained with MAb 5–11 (A, B) andMAb 3NB12 (C, D), which recognize pharyngeal muscles (Miller et al., 1986; Priess and Thomson, 1987),
and MAb MH4 (E, F) recognizing intermediate filaments in the marginal cells (Francis and Waterston, 1991). In panel F, the approximate extent of the mc1, mc2, and
mc3 marginal cells is indicated (Albertson and Thomson, 1976). Note the marginal cells extend the length of the pharynx in (E), suggesting that mc1 and mc2 cells are
present in tbx-2(ok529) mutants.
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(pk1426) background.
ABa-derived pharynx requires glp-1, and loss of glp-1
results in loss of anterior pharyngeal development as well as
other embryonic defects (Priess et al., 1987). glp-1(RNAi)
resulted in highly penetrant embryonic arrest with disorganized
embryos having only the posterior half of the pharynx (Figs.
4A, B). Transgenic embryos contained 11 ceh-22∷gfp expres-
sing cells (Table 2). This number of cells is near that observed in
tbx-2(RNAi) animals and is consistent with loss of ABa-derived
pharyngeal muscles. tbx-2(RNAi); glp-1(RNAi) produced a
similar embryonic arrest (Figs. 4C, D), and when compared to
tbx-2(RNAi) or glp-1(RNAi) alone, these tbx-2(RNAi);glp-1
(RNAi) double mutants exhibited only a slight reduction in the
number of ceh-22∷gfp expressing cells (Table 2). These results
strongly suggest that tbx-2(RNAi) animals lack most if not all
ceh-22 expressing pharyngeal muscles derived from ABa.
MS-derived pharynx requires med-1 and med-2, which
encode nearly identical, redundant GATA factors (Maduro et al.,
2001). Because of high sequence identity, med-1(RNAi)
simultaneously eliminates activity of both genes and results inTable 1
tbx-2(ok529) mutants have fewer pharyngeal muscles than wild type
Genotype Average number of cells expressing
ceh-22∷gfp (n) a
cuEx353[ceh-22∷gfp] 17.9 ± 1.8 (44)
tbx-2(ok529); cuEx363[ceh-22∷gfp] b 12.2 ± 1.8 (32)
a n = number of animals scored foe each genotype. Non-transgenic animals
that have lost the extrachromosal array are not included.
b Arrested tbx-2(ok529); cuEx353 larvae segregating from tbx-2(ok529)/dpy-
17(e164) + unc-32(e189); cuEx353.
Fig. 3. tbx-2 mutants contain fewer ceh-22∷gfp expressing pharyngeal muscles
than wild-type animals. Fluorescence (A, C) and DIC (B, D) micrographs of
wild-type (A, B) and tbx-2(ok529) (C, D) L1 larvae expressing ceh-22∷gfp.
This reporter is strongly expressed in the pharyngeal muscles of wild-type and
tbx-2(ok529) animals, but the number of ceh-22∷gfp expressing cells is reduced
in tbx-2 mutants. GFP is tightly localized to pharyngeal muscle nuclei. In these
and the following figures, GFP expressing cells were found and counted in
multiple focal planes, and representative focal planes are shown.
Table 2
tbx-2 and ubc-9 are required for ABa-derived pharyngeal muscle
Genotype a Expected number of ceh-22
expressing cells/animal
Number ceh-22∷gfp
expressing cells/animal (n) b
Expected % transgenic
animals
% Animals expressing
ceh-22∷gfp (n) c
+/+ 21 16.7 ± 1.9 (79) 75 77 (45)
tbx-2(RNAi) 14 d 12.1 ± 1.2 (50) e 75 78 (64)
glp-1(RNAi) 14 11.0 ± 1.2 (61) e 75 78 (78)
tbx-2(RNAi); glp-1(RNAi) 14 d 10.1 ± 1.6 (45) e 75 78 (58)
med-1(RNAi) 7 6.6 ± 0.7 (52) e 75 81 (64)
tbx-2(RNAi); med-1(RNAi) 0 d n.d. f 75 38 (71)
ubc-9(RNAi) 14 d 13.1 ± 1.2 (42) e 75 n.d.
ubc-9(RNAi); glp-1(RNAi) 14 d 11.3 ± 1.5 (52) e 75 n.d.
ubc-9(RNAi); tbx-2(RNAi) 14 d 12.3 ± 1.4 (45) e 75 n.d.
a All RNAi experiments were done in a rrf-3(pk1426); cuIs22[ceh-22∷gfp]/+genetic background, but this genotype is left out for clarity.
b n = total number of control (top row) or RNAi affected animals bearing the cuIs22[ceh-22∷gfp] transgene scored.
c n = total number of control (top row) or RNAi affected animals expressing ceh-22∷gfp in any cells.
d Number expected if tbx-2 and ubc-9 are required for ABa-derived pharyngeal muscle.
e Statistically significant difference from control animals (P < 0.0001).
f The average number of ceh-22∷gfp expressing cells could not be accurately determined inmed-1(RNAi) because we were unable to distinguish transgenic and non-
transgenic animals. See text for details.
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embryonic defects (Maduro et al., 2001). med-1(RNAi) resulted
in embryonic arrest with embryos containing only the anterior
half of the pharynx (Figs. 4E, F), and although the penetrance of
this phenotype was higher in rrf-3(pk1426) than in wild type,
this effect was still less penetrant than tbx-2(RNAi) or glp-1
(RNAi). med-1(RNAi) affected embryos bearing the transgene
contained approximately 7 ceh-22∷gfp expressing cells (Table
2). This number of cells is consistent with those expected from
ABa lineage, indicating that med-1(RNAi) was effective. tbx-2
(RNAi); med-1(RNAi) produced a mixture of phenotypes,
including animals that appeared to lack function of both tbx-2
and med-1/2. These putative tbx-2(RNAi); med-1(RNAi)
embryos often contained a visible buccal cavity and pharyngeal
basement membrane, but they had no ceh-22∷gfp expressing
cells, as expected if both ABa- and MS-derived pharyngeal
muscles were missing (Figs. 4G, H). However, the strain used
for this experiment was heterozygous for cuIs22[ceh-22∷gfp],Fig. 4. tbx-2 mutants lack ABa-derived pharyngeal muscles. Fluorescence (top) an
genotype of these embryos is indicated above the micrographs. Arrowheads in panels
muscles. (H) The buccal cavity and pharyngeal basement membrane are marked by an
in fluorescence and as refractile particles in DIC.and we were unable to obtain a cuIs22 homozygous strain in the
rrf-3 mutant background. Thus, we could not be certain if
individual arrested progeny were transgenic. To determine
whether tbx-2(RNAi); med-1(RNAi) eliminated all pharyngeal
muscle differentiation, we compared the fraction of RNAi
affected embryos containing any cells that express ceh-22∷gfp
in all of our experiments (Table 2). We expect the cuIs22
transgene will segregate to 75% of the embryos, and in most
cases, we observed ceh-22∷gfp expression at this frequency in
the RNAi affected animals. Only in tbx-2(RNAi); med-1(RNAi)
did we observe a reduced frequency of animals expressing ceh-
22∷gfp, indicating many tbx-2(RNAi); med-1(RNAi) transgenic
animals lacked both ABa- and MS-derived pharyngeal muscles.
Taken together, these results indicate tbx-2mutants lack most
or all ABa-derived pharyngeal muscles and retain MS-derived
pharyngeal muscles. By comparison, ABa-derived pharyngeal
marginal cells do not appear to be missing in tbx-2mutants. The
mc1 and mc2 marginal cells that extend through the corpus andd DIC (bottom) micrographs of arrested embryos expressing ceh-22∷gfp. The
A–F indicate the partial pharynx containing ceh-22∷gfp expressing pharyngeal
arrow and arrowhead. respectively. Autofluorescent gut granules (g) are visible
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Thomson, 1976; Sulston et al., 1983), yet at least some of these
cells were present in tbx-2(ok529) mutants (Figs. 2E, F). Thus,
tbx-2 appears to be primarily required for production of ABa-
derived pharyngeal muscle.
A tbx-2∷gfp reporter is expressed in a dynamic pattern in
transgenic embryos
tbx-2 expression has previously been observed in a subset of
pharyngeal and non-pharyngeal neurons in larvae using a gfp
reporter gene containing the entire tbx-2 gene and 1.6 kb of 5′-
flanking DNA (Miyahara et al., 2004). We examined transgenic
animals bearing this tbx-2∷gfp reporter (kindly provided by I.
Katsura) and found expression initiated in the pharyngeal
neurons in late embryogenesis, but earlier expression was not
observed. As this expression begins after tbx-2 function is
required to specify pharyngeal muscle fate, additional promoter
sequences necessary for earlier embryonic expression were
likely missing from this reporter. We constructed another tbx-
2∷gfp reporter containing more extensive flanking sequences,
including all intergenic regions and extending into adjacent
genes. This reporter (pAW209) contains the entire tbx-2 gene
and 4 kb of 5′-flanking DNA (bp 21041 of cosmid F21H11,
accession #U11279, through bp 2591 of cosmid Y54H5A,
accession #AC024818) with the gfp coding sequence inserted
in-frame in the last tbx-2 exon. It encodes full-length TBX-2
protein with GFP inserted downstream of the T-box after
residue 378. This full-length fusion protein is nuclear localized
and likely binds DNA with its intact T-box, but it does not
rescue tbx-2(ok529) (data not shown).
In transgenic embryos, this larger tbx-2∷gfp reporter was
expressed in a dynamic pattern, including in a subset of
pharyngeal precursors in the premorphogenetic embryo, as well
as body wall muscle and pharyngeal neurons. tbx-2∷gfp
expression initiated in 2 anterior cells in approximately 100
cell embryos and increased to 12 cells by approximately the 200
cell stage (Figs. 5A–D). The increasing number of GFP
expressing cells was not due to cell divisions; rather tbx-2∷gfp
expression appeared to initiate asynchronously in individual
cells. Expression in these cells was transient and was
undetectable by the bean stage. Prior to the bean stage, tbx-Fig. 5. tbx-2∷gfp expression in wild-type animals. (A–F) Fluorescence (left)
and DIC micrographs (right) of embryos expressing a full-length tbx-2∷gfp
fusion (pAW209). (A, B) Approximately 100 cell stage expressing TBX-
2∷GFP in 2 nuclei (arrowheads). (C, D) Approximately 200 cell stage
expressing TBX-2∷GFP in 12 pharyngeal precursors. TBX-2∷GFP disappears
in pharyngeal precursors shortly after this stage. (E, F) Comma stage embryo
expressing TBX-2∷GFP in body wall muscle (bw) nuclei. One body wall
muscle quadrant is visible in this focal plane. (G–L) Fluorescence and DIC
micrographs of 3-fold embryos (G-J) and an L1 larva (K, L) expressing a tbx-
2∷gfp promoter fusion in pharyngeal muscles (pOK206.30). This reporter
encodes TBX-2 residues 1–10 fused to GFP, and this fusion protein perdures
longer than full-length TBX-2∷GFP. Representative pharyngeal muscles
expressing GFP are marked. Expression in the m1 and m2 muscles was clearly
visible in the occasional animals lacking strong expression in the m3 cell (M).
Schematic diagram of the pharyngeal muscles with the positions of nuclei
indicated (grey ovals). Adapted from Albertson and Thomson (1976).2∷gfp expression was also observed in body wall muscles, and
later, in 2- to 3-fold embryos, expression was observed in a
number of pharyngeal neurons (Figs. 5E, F; data not shown).
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Embryos at the ~200 cell stage contain 24 clonally committed
pharyngeal precursors located in the anterior of the embryo (13
ABa-derived and 11 MS-derived) (Kalb et al., 1998; Sulston et
al., 1983), and the location of the 12 tbx-2∷gfp expressing cells
at this stage suggests that they are included among these
precursors. To determine if these early tbx-2∷gfp expressing
cells were indeed pharyngeal precursors and to characterize
their lineal origin, we examined expression of a tbx-2∷gfp
promoter fusion containing the same tbx-2 5′-flanking
sequences characterized above fused to gfp just downstream
of the tbx-2 translation initiation codon (pOK206.30). Previous
studies demonstrated that such promoter fusions can produce a
longer lived GFP signal than full-length protein fusions (Good
et al., 2004). This tbx-2∷gfp promoter fusion produced
cytoplasmic GFP first detected in premorphogenetic embryos
in the same pattern as full-length fusion protein, but GFP
perdured in the pharynx until near hatching (Figs. 5G–L). We
observed GFP expression in 3-fold embryos and early larvae in
a reproducible subset of pharyngeal muscles, with occasional
expression in body wall muscles and head neurons (Table 3).
The pharynx contains 20 muscle cells of 8 distinct types termed
m1–m8 (Fig. 5M), and many of these are multinucleate cells
produced by fusion of 2 or more cells near the time of hatching
(Albertson and Thomson, 1976; Sulston et al., 1983). Of these,
the m1 and m2 muscles are solely derived from ABa, whereas
the m6, m7, and m8 muscles are solely derived from MS. The
remainder of the pharyngeal muscle types are of mixed lineal
origin, consisting of both ABa- and MS-derived cells. We
observed GFP predominantly in pharyngeal muscle types
derived solely from ABa or from mixed lineages, and the
number of these GFP-positive cells was generally consistent
with those containing ABa-derived cells (Figs. 5G–L; Table 3).
However, exceptions to this generalization were found. Most
notably, GFP was reproducibly observed in one MS-derived m7
muscle and all three m4 muscles (of which 2 contain only MS-Table 3
Pharyngeal muscle types expressing a long-lived TBX-2∷GFP
Pharyngeal
muscle
type a
Number of cells containing
ABa-derived nuclei/number
of total cells a
Expressing
tbx-2∷gfp in
3-fold stage
Number of GFP
expressing cells
Muscles derived from Aba
m1 1/1 Yes n.d. b
m2 3/3 Yes n.d. b
Muscles derived from ABa and MS
m3 2/3 Yes 1
m4 1/3 Yes 3
m5 2/3 Yes 2
Muscles derived from MS
m6 0/3 No 0
m7 0/3 Yes 1
m8 0/1 No 0
a For a description of pharyngeal muscles and lineal origins (Albertson and
Thomson, 1976; Sulston et al., 1983).
b n.d. = not determined. m1 and m2 muscles could not be examined in most
animals due to strong fluorescence in the m3 muscle.derived cells) (Table 3). Taken together, these results strongly
suggest that tbx-2∷gfp expression in premorphogenetic embry-
os is limited to pharyngeal precursors, and most of these are
ABa-derived, although expression is also likely in a small
number of MS-derived pharyngeal precursors.
The SUMO conjugating enzyme UBC-9 interacts with TBX-2
and is similarly required for ABa-derived pharyngeal muscles
T-box proteins often bind to other proteins to control tissue
differentiation (Bruneau et al., 2001; Garg et al., 2003; Hiroi et
al., 2001; Stennard et al., 2003). To identify proteins interacting
with TBX-2, we performed a yeast two-hybrid screen using a
full-length TBX-2 bait. This bait alone did not activate
transcription, suggesting that TBX-2 does not contain a strong
transcriptional activation domain active in yeast. In a screen of a
library containing C. elegans cDNAs fused to the GAL4
activation domain, we identified two components of the
Sumoylation pathway, UBC-9 and GEI-17, that interact
specifically with TBX-2. UBC-9 is the E2 SUMO-conjugating
enzyme, and GEI-17 is an E3 SUMO-ligase closely related to
the PIAS (protein inhibitor of activated STAT) family. TBX-2
contains 2ΨKX(E/D) consensus sumoylation sites (whereΨ is
a large hydrophobic amino acid and K is the residue attached to
SUMO) located in the T domain and near the C-terminus (Fig.
6). These sites in other proteins are sufficient to mediate
interaction with UBC-9 (Bernier-Villamor et al., 2002;
Sampson et al., 2001).
Sumoylation is known to affect the activity and subcellular
localization of transcription factors (reviewed in Girdwood et
al., 2004), and it is essential for viability in C. elegans (Broday
et al., 2004; Jones et al., 2002; Tsuboi et al., 2002; Zhang et al.,
2004). If one early function of sumoylation is to promote TBX-
2 activity, loss of sumoylation pathway components should
produce phenotypes similar to loss of tbx-2. We tested this
prediction by examining the phenotype of ubc-9(RNAi) animals
and found that these animals do indeed resemble tbx-2 mutants.
ubc-9(RNAi) has previously been shown to result in embryonic
and larval lethality (Jones et al., 2002), and we observed a
similar range of phenotypes produced after injection of ubc-9
dsRNA into wild-type animals. While most ubc-9(RNAi)
animals arrested as abnormal embryos, approximately 10% of
the ubc-9(RNAi) animals hatched and arrested as L1 larvae
exhibiting highly penetrant anterior pharyngeal defects strik-
ingly similar to those in tbx-2mutants (Fig. 7A). To determine if
this similarity reflected a reduced number pharyngeal muscle
cells, we counted ceh-22∷gfp expressing cells in both arrested
ubc-9(RNAi) embryos and larvae, and we found that these
animals contained a reduced number of pharyngeal muscle cells
comparable to the number found in tbx-2 mutants (Table 2; Fig.
7B). The number of ceh-22∷gfp expressing cells was not
substantially reduced in either ubc-9(RNAi); glp-1(RNAi) or
ubc-9(RNAi); tbx-2(RNAi) (Table 2; Figs. 7C, D), indicating
that as in tbx-2mutants, most or all pharyngeal muscles in ubc-9
(RNAi) animals are MS derived.
gei-17(RNAi) also resulted in pharyngeal defects similar to
those in weakly affected tbx-2(RNAi) animals. gei-17(RNAi) has
Fig. 6. Consensus sumoylation sites in TBX-2. Schematic diagram indicating
positions of the ΨKX(E/D) consensus sumoylation sites in TBX-2. The
sequence and positions of these sites are indicated.
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larval growth defects (Simmer et al., 2003; Tsuboi et al., 2002).
We primarily observed slow growth and larval arrest when gei-
17(RNAi) was performed in a wild-type background. In newly
hatched animals, 18% of gei-17(RNAi) animals exhibited
pharyngeal defects similar to those of weakly affected tbx-2
(RNAi) animals (n = 101) (Fig. 8A), whereas these defects were
never observed in control animals (n = 65). When gei-17(RNAi)
animals were examined at the L3–L4 stage, 18% of the animals
exhibited a thick pharyngeal isthmus nearly identical to that
observed in viable tbx-2(RNAi) animals (n = 55) (Fig. 8B), and
this defect was not observed in control animals (n = 30). The
severity of these pharyngeal defects was not strongly enhanced
when gei-17(RNAi) was examined in the RNAi hypersensitive
rrf-3(pk1426) background (data not shown), and we did not
observe gei-17(RNAi) animals lacking anterior pharynx. The
relatively mild pharyngeal defects in gei-17(RNAi) animals may
result from the fact that E3 SUMO ligases increase the
efficiency of sumoylation but are not essential for thisFig. 7. ubc-9(RNAi) animals lack ABa-derived pharyngeal muscles. ubc-9
(RNAi) animals exhibit pharyngeal defects (A) and loss of ceh-22∷gfp
expressing cells (B) in a manner identical to tbx-2 mutants. tbx-2(RNAi); ubc-
9(RNAi) double mutants exhibit pharyngeal morphology (C) and number of ceh-
22∷gfp expressing cells similar to each single mutant. Brackets indicate ceh-
22∷gfp expressing cells in panels B and D. Note that panels A and B are
different animals.modification (Bernier-Villamor et al., 2002; Sampson et al.,
2001).
Sumoylation often regulates localization of target proteins
(Johnson, 2004), and we found that normal nuclear localization
of full-length TBX-2∷GFP requires ubc-9. In wild-type
animals, TBX-2∷GFP is predominantly distributed uniformly
in early embryonic and body wall muscle nuclei, with only faint
accumulation of GFP in subnuclear puncta (Fig. 9C). In
contrast, in ubc-9(RNAi) animals TBX-2∷GFP was much more
strongly localized to nuclear puncta (Figs. 9A, B, D). We
suggest that ubc-9 directly affects subnuclear localization of
TBX-2 by sumoylation.
Discussion
T-box transcription factors are involved in development of
ABa-derived pharynx
Cell fates in the AB lineage of C. elegans are profoundly
influenced by GLP-1/Notch-mediated signals (reviewed in
Schnabel and Priess, 1997). At the 12-cell stage, a contact-
mediated signal from the MS blastomere activates the GLP-1/
Notch receptor and induces cell fates in two ABa grand-
daughters, ABara and ABalp (Hutter and Schnabel, 1994;
Mango et al., 1994; Moskowitz et al., 1994; Priess et al., 1987).
ABara and ABalp ultimately give rise to a variety of cell types,
including muscle and non-muscle cells in the anterior pharynx,
as well as non-pharyngeal cells (Sulston et al., 1983).
Here, we show that C. elegans tbx-2 promotes development
of pharyngeal muscles derived from the ABa lineage. In
comparison, non-pharyngeal cells produced by ABa do not
require tbx-2, as tbx-2 mutants do not exhibit morphological
abnormalities outside the pharynx or embryonic lethality
characteristic of mutants more generally affecting ABa
development (Good et al., 2004; Lambie and Kimble, 1991;
Priess et al., 1987). Likewise, at least some non-muscle
pharyngeal cells produced by ABa also do not require tbx-2,
as ABa-derived mc1 and mc2 marginal cells are present in tbx-2Fig. 8. gei-17(RNAi) results in pharyngeal defects. DIC micrographs showing
the pharynx of gei-17(RNAi) L1 (A) and L3 (B) animals. The terminal bulb (tb),
metacorpus (mc), and an abnormally thick isthmus (i) are indicated. Arrowheads
in panel A indicate an abnormally narrow procorpus similar to that observed in
weak tbx-2(RNAi) animals. Anterior is left; scale bar indicates 20 μm.
Fig. 9. TBX-2∷GFP localization is altered in ubc-9(RNAi). (A, B) Approxi-
mately comma stage ubc-9(RNAi) embryo expressing TBX-2∷GFP in body
wall muscle. This embryo is at a stage comparable to the wild-type animal in
Figs. 5E, F. (C, D) Higher magnification images of TBX-2∷GFP in body wall
muscle nuclei of wild-type (C) and ubc-9(RNAi) embryos (D) with
representative nuclei circled. In ubc-9(RNAi) embryos TBX-2∷GFP is
preferentially localized to puncta within cell nuclei (arrow). These puncta are
visible in wild-type embryos, although TBX-2∷GFP localization is more
uniform throughout cell nuclei.
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pharyngeal muscles missing in tbx-2 mutants (Sulston et al.,
1983), indicating that the requirement for tbx-2 is distinct even
in closely related pharyngeal cells. Thus, we hypothesize that
tbx-2 is primarily required for ABa-derived pharyngeal muscle
development.
The expression pattern of our tbx-2∷gfp reporters provides
the first evidence for tbx-2 expression in embryos (Miyahara et
al., 2004) and is in large part consistent with a function for tbx-2
in specifying ABa-derived pharyngeal muscle fate. A full-
length tbx-2∷gfp protein fusion is transiently expressed in 12
likely pharyngeal precursors prior to the formation of the
pharyngeal primordium, and while we have not precisely
identified these cells, a tbx-2∷gfp promoter fusion producing a
more stable GFP marks a subset of pharyngeal muscles,
including each of the muscle types derived from ABa. Thus, we
hypothesize that tbx-2 is preferentially expressed in ABa-
derived pharyngeal precursors. However, as this fusion also
marks a small number of MS-derived muscles (e.g., m7), we
cannot rule out tbx-2 expression and function in a subset of MS-
derived pharyngeal muscles. We are currently generating
antibodies to confirm that tbx-2∷gfp accurately reflects
expression of endogenous tbx-2 and to precisely identify tbx-2
expressing cells.
The expression pattern and function of tbx-2 are distinct from
those of the T-box genes tbx-37 and tbx-38, which have recently
been found to function redundantly in ABa development (Good
et al., 2004). tbx-37/38 are transiently expressed earlier than tbx-
2 at the 24-cell stage, and expression is undetectable by the time
tbx-2∷gfp expression begins. Likewise loss of tbx-37/38 affects
development of all ABa-derived pharyngeal as well as other
ABa-derived tissues. Thus, tbx-37/38 are believed to promote
all cell fates in the ABa lineage in combination with GLP-1
signaling (Good et al., 2004), and they likely function upstream
of tbx-2.Protein sumoylation is required for ABa-derived pharyngeal
muscles
Sumoylation is the reversible post-translational attachment
of the small ubiquitin-like modifier (SUMO) peptide to specific
lysine residues in target proteins, and it has been implicated in
diverse processes, including modifying function, nuclear
localization, and subnuclear localization of transcriptional
regulators (reviewed in Gill, 2004; Johnson, 2004). The
SUMO conjugation pathway is analogous to the ubiquitination
pathway and involves an E1 activating enzyme (Aos1/Uba2)
and an E2 conjugating enzyme (Ubc-9) sufficient for specific
SUMO attachment in vitro (Desterro et al., 1999; Okuma et al.,
1999). In addition, a variety of E3 ligases have been identified
that promote SUMO transfer from E2 to specific substrates. E2/
Ubc-9 recognizes the ΨKX(D/E) consensus sumoylation site
(Bernier-Villamor et al., 2002; Sampson et al., 2001), and many
sumoylation substrates have been identified by their interaction
with Ubc-9 in yeast two-hybrid screens (Johnson, 2004).
UBC-9 is the only E2 SUMO conjugating enzyme encoded
in the C. elegans genome, and previous analyses indicate that
ubc-9(RNAi) causes pleiotropic defects and variable embryonic
or larval arrest (Jones et al., 2002; Leight et al., 2005; Zhang et
al., 2004). We show here that ubc-9(RNAi) animals exhibit
pharyngeal abnormalities and a loss of ABa-derived pharyngeal
muscle strikingly similar to tbx-2 mutants. Many ubc-9(RNAi)
animals exhibit earlier embryonic arrest than tbx-2 mutants,
suggesting that other developmental regulatory proteins require
sumoylation. In C. elegans, sumoylation has thus far been
implicated in regulating activity of the Polycomb group protein
SOP-2, the LIM domain transcription factor LIN-11, and ETS
domain transcription factor LIN-1 (Broday et al., 2004; Leight
et al., 2005; Zhang et al., 2004). As these proteins function
during post-embryonic development, UBC-9 likely targets
additional unidentified proteins that function during embryonic
development.
TBX-2 is a likely target for UBC-9-mediated sumoylation in
vivo
TBX-2 interacts specifically in yeast two-hybrid assays with
both UBC-9 and GEI-17, the E2 SUMO conjugating enzyme
and the E3 SUMO ligase respectively, and these interactions
likely reflect in vivo interactions required for TBX-2 function in
C. elegans. In addition to the similar phenotypes observed in
tbx-2 mutants and ubc-9(RNAi) animals, the localization pattern
of a TBX-2∷GFP fusion protein is altered by ubc-9(RNAi),
such that TBX-2∷GFP is more strongly localized to subnuclear
puncta. The identity and function of these puncta are unclear,
but we hypothesize that sumoylation is necessary for TBX-2
function by promoting its distribution in the nucleoplasm.
In many cases, sumoylation is necessary for proper
localization of nuclear proteins (reviewed in Johnson, 2004).
Sumoylation was initially discovered as a modification required
for the localization of the nuclear import factor RanGAP1 to the
nuclear pore complex (Mahajan et al., 1997; Matunis et al.,
1996), and it has subsequently been shown to regulate nuclear
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Dorsal, and the mammalian IKB kinase regulator NEMO and
Elk-1 transcription factor (Bhaskar et al., 2002; Epps and Tanda,
1998; Huang et al., 2003; Salinas et al., 2004). Sumoylation is
also necessary for the assembly and localization of a variety of
proteins including PML and SP100 in PML nuclear bodies
(Johnson, 2004), which are believed to function as storage
depots for nuclear factors, or sites of protein modification and
complex formation. In C. elegans, sumoylation similarly
promotes localization of SOP-2 and LIN-11 to subnuclear
bodies (Broday et al., 2004; Zhang et al., 2004). The function of
sumoylation on TBX-2 localization appears different than for
either SOP-2 or LIN-11, as sumoylation promotes localization
of TBX-2 to the nucleoplasm.
TBX-2 contains 2 consensus ΨKX(E/D) sumoylation sites,
located in the T-box and near the C-terminus, respectively, and
several weaker predicted sumoylation sites distributed through
the protein, and many of these sites are conserved in TBX-2
from the related nematode C. briggsae (Stein et al., 2003).
Interestingly, the consensus site near the TBX-2 C-terminus has
diverged in C. briggsae, but another potential sumoylation site
(GKKE) is located immediately upstream in the C. briggsae
protein. The consensus site in the T-box (LKIE) is highly
conserved in vertebrate Tbx2 subfamily members (Papaioan-
nou, 2001). By comparison to the crystal structure of human
TBX3 (Coll et al., 2002), this site is predicted to be located in
the α3 helix, which contacts DNA, and thus, sumoylation of this
site could affect TBX-2 DNA binding.
Sumoylation is generally associated with transcriptional
repression (reviewed in Johnson, 2004). In C. elegans,
sumoylated SOP-2 represses expression of homeotic genes
(Zhang et al., 2004), and sumoylation of LIN-1 is believed to
recruit the NuRD transcriptional repression complex through
the interaction with the zinc finger protein MEP-1 (Leight et al.,
2005). As target genes regulated by TBX-2 have not yet been
identified in C. elegans, we do not know if TBX-2 functions as a
transcriptional repressor or activator. However, mammalian
Tbx2 and Tbx3 do function as transcriptional repressors
(Carlson et al., 2001; Carreira et al., 1998; He et al., 1999),
and indeed, C. elegans TBX-2 alone does not activate
transcription in yeast. Thus, TBX-2 may function as a repressor,
and this function likely depends on sumoylation.
tbx-2 functions in other tissues
T-box genes are frequently expressed in a multiple tissues,
where they carry out distinct functions (reviewed in
Papaioannou, 2001). For example, murine Tbx2 is expressed
in embryonic tissues including the heart, optic and otic
vesicles, lung, and mammary gland (Chapman et al., 1996;
Christoffels et al., 2004; Gibson-Brown et al., 1996; Habets et
al., 2002).
C. elegans tbx-2 also likely functions in multiple tissues. In
addition to ABa-derived pharyngeal precursors, tbx-2∷gfp is
expressed body wall muscles and pharyngeal neurons. Neuronal
expression underlies tbx-2 function in olfactory adaptation
(Miyahara et al., 2004), and while we have not yet carefullyexamined tbx-2 function in body wall muscles, tbx-2 mutants
appear to exhibit body wall muscle positioning defects (S.A.
and A.W., unpublished).
Relationship between tbx-2 and T-box factors in other species
Vertebrate Tbx2 subfamily genes related to C. elegans tbx-2
function in heart development (reviewed in Plageman and
Yutzey, 2005). Tbx2, Tbx3, and Tbx5 are expressed in the
developing heart, and mouse Tbx5 and Tbx2 mutants exhibit
defects in heart development (Bruneau et al., 2001; Harrelson et
al., 2004). In the heart, Tbx5 interacts directly with the NK-2
family homeodomain factor Nkx2.5 to synergistically activate
target gene expression (Bruneau et al., 2001; Hiroi et al., 2001),
whereas Tbx2 and Tbx3 suppress Nkx2.5-mediated gene
activation (Habets et al., 2002; Hoogaars et al., 2004).
C. elegans pharyngeal muscle exhibits functional and
molecular similarities to cardiac muscle in other organisms. In
particular, the Nkx2.5-related homeobox gene ceh-22 is required
for normal pharyngeal muscle development (Okkema et al.,
1997), and ceh-22 mutants can be rescued by pharyngeal
muscle expression of zebrafish Nkx-2.5 (Haun et al., 1998). The
requirement for tbx-2 in pharyngeal muscle suggests another
molecular similarity between the C. elegans pharynx and
vertebrate heart.
It is not yet clear however that tbx-2 function in the C.
elegans pharynx is the same as T-box transcription factors in the
vertebrate heart. Both weakly affected tbx-2(RNAi) animals and
ceh-22 mutants exhibit a hypertrophied pharyngeal isthmus,
suggesting that these genes may regulate common targets
(Okkema et al., 1997), but we have not observed direct
interaction between TBX-2 and CEH-22 (S.R.C. and P.G.O.,
unpublished), as has been observed for Tbx5 and Nkx2.5
(Bruneau et al., 2001; Hiroi et al., 2001). Likewise we have not
observed rescue of C. elegans tbx-2 mutants by expression of
murine Tbx2 (S.A. and A.W., unpublished). As C. elegans tbx-2
is the only Tbx2 subfamily gene in C. elegans, perhaps it
performs multiple functions that have become specialized to
individual Tbx2 subfamily members as this family expanded
during vertebrate evolution.
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